MOORESTOWN, N.J., April 21, 2020 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare, Inc® (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, and Antimicrobial Therapy Inc., publisher and developer of The Sanford Guide, today announced a collaboration to make Sanford Guide easily accessible from within DoseMeRx™, TRHC’s precision dosing solution.
The agreement includes the addition of links to Sanford Guide’s clinically relevant anti-infective drug information and guidelines for the treatment of infectious diseases. Sanford Guide Web Edition and Sanford Guide All Access customers can now seamlessly access their subscription-based resources directly from within DoseMeRx, reducing the time needed to evaluate treatment considerations.“Sanford Guide’s mission is to provide clinically actionable guidelines to providers in the most convenient way possible,” said Sanford Guide’s Vice President, Scott Kelly. “Our collaboration with Tabula Rasa HealthCare and DoseMeRx helps us achieve this by providing pertinent Sanford Guide content with a single click. We’re excited to add this time-saving feature for our mutual clients.”Trusted by clinicians in more than 100 countries, The Sanford Guide helps to minimize time-to-answer while providing comprehensive guidance at the point of care. Edited by distinguished infectious disease experts from leading academic and clinical centers, Sanford Guide content provides comprehensive coverage of treatment options for infectious disease, syndromes, and pathogens.“Our goal is to improve patient outcomes while minimizing technology burdens on providers,” said TRHC Chairman and CEO Calvin H. Knowlton, PhD. “By making Sandford Guide available through DoseMeRx, we reduce the workload for pharmacy in healthcare organizations across the country.”According to TRHC Executive Vice President for DoseMeRx, Charles Cornish, “The addition of Sanford Guide will save mutual clients using DoseMeRx crucial time in accessing the latest, updated quality clinical resources needed to enhance patient care.”About Tabula Rasa HealthCare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize performance to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com.About DoseMeRx
DoseMeRx is a Tabula Rasa HealthCare (NASDAQ: TRHC) solution. It is the first precision dosing software developed specifically for clinical practice. The DoseMeRx clinical decision support platform empowers healthcare providers to optimize dosing of high-risk parenteral medications to streamline operations, reduce adverse drugs events, decrease costs and improve patient outcomes. For more information on DoseMeRx, visit doseme-rx.comAbout Sanford Guide
Sanford Guide provides industry-leading point-of-care guidelines for the treatment of infectious diseases. Widely used by pharmacists, physicians, physician assistants, and nurses, Sanford Guide improves patient care by delivering carefully curated recommendations based on the latest evidence. Sanford Guide takes pride in responsiveness to customers, the development of innovative solutions, and providing content that is unparalleled in quality and clinical utility. For more information on Sanford Guide, visit sanfordguide.comForward-Looking Statements
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 1, 2019, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website http://ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.
Bay Street News
